journal
MENU ▼
Read by QxMD icon Read
search

Expert Review of Anti-infective Therapy

journal
https://www.readbyqxmd.com/read/27911112/treatment-of-alpha-and-beta-herpesvirus-infections-in-solid-organ-transplant-recipients
#1
C L Abad, R R Razonable
Human herpesviruses frequently cause infections in solid organ transplant (SOT) recipients. Areas covered: We provide an overview of the clinical impact of alpha and beta herpesviruses and highlight the mechanisms of action, pharmacokinetics, clinical indications, and adverse effects of antiviral drugs for the management of herpes simplex virus, varicella zoster virus and cytomegalovirus. We comprehensively evaluated key clinical trials that led to drug approval, and served as the foundation for management guidelines...
December 2, 2016: Expert Review of Anti-infective Therapy
https://www.readbyqxmd.com/read/27910715/how-do-we-measure-adherence-to-anti-tuberculosis-treatment
#2
Salomé Valencia, Montserrat León, Irene Losada, Victor G Sequera, Manuel Fernandez Quevedo, Alberto L García-Basteiro
Completion of anti-tuberculosis (TB) treatment is of paramount importance for TB patients, as well as for the global efforts of TB control. However, there is neither a gold-standard measure to monitor adherence to TB treatment nor a widely used definition for different levels of adherence. Areas covered: in this review we aim to describe the different methods used to measure patients' adherence to anti-TB treatment, identifying their main strengths and limitations, with a focus on low resource settings. Expert commentary: there is a need for continuing the quest for a low cost, reliable and acceptable measure of adherence to TB treatment...
December 2, 2016: Expert Review of Anti-infective Therapy
https://www.readbyqxmd.com/read/27910709/management-of-infections-associated-with-neurosurgical-implanted-devices
#3
Anna Conen, Christoph A Fux, Peter Vajkoczy, Andrej Trampuz
Neurosurgical devices are increasingly used. With it, neurosurgical device-related infections gain relevance. As biofilms are involved in implant-associated infections the diagnosis and treatment is challenging and requires specific anti-biofilm concepts and management algorithms. Areas covered: The literature concerning the management of neurosurgical device-associated infections is scarce and heterogeneous treatment concepts are discussed, but no standardized diagnostic and treatment procedures exist. Therefore, we emphasize extrapolating management strategies predominantly from orthopedic device-associated infections, where the concept is better established and clinically validated...
December 2, 2016: Expert Review of Anti-infective Therapy
https://www.readbyqxmd.com/read/27882822/a-protective-role-for-herpes-simplex-virus-type-1-specific-humoral-immunity-in-alzheimer-s-disease
#4
Simone Agostini, Roberta Mancuso, Francesca Baglio, Mario Clerici
No abstract text is available yet for this article.
December 1, 2016: Expert Review of Anti-infective Therapy
https://www.readbyqxmd.com/read/27894204/clinical-laboratory-assessments-for-mycoplasma-genitalium-in-a-high-prevalence-sexually-transmitted-infection-community-reveal-epidemiologic-dichotomies-with-trichomonas-vaginalis
#5
Erik Munson, Kimber L Munson, Ronald F Schell
Mycoplasma genitalium is an emerging agent of sexually-transmitted infection and is responsible for clinically-significant genital tract disease in both females and males. Similar to scenarios recently experienced with the urogenital flagellate Trichomonas vaginalis, an evolving molecular diagnostic reference standard based on transcription-mediated amplification allows for accurate detection of the organism, plus additional insight into disease epidemiology. Areas covered. The basis for this article includes primary peer-reviewed literature plus compilations of data derived from routine clinical laboratory screening of females and males for agents of sexually-transmitted infection...
November 29, 2016: Expert Review of Anti-infective Therapy
https://www.readbyqxmd.com/read/27885885/septic-encephalopathy-and-septic-encephalitis-%C3%A2-%C3%A2-%C3%A2-%C3%A2
#6
Simone C Tauber, Helmut Eiffert, Wolfgang Brück, Roland Nau
During the last two decades, septic encephalopathy (SE) was recognized as a clinically relevant problem with a high prevalence in patients at admission and during their hospital stay. SE is a condition associated with increased mortality and morbidity such as long-term cognitive impairment. Areas covered: This review illustrates the pathophysiology of sepsis-associated encephalopathy and encephalitis involving blood-brain-barrier dysfunction and neuroinflammation caused by endothelial and microglial activation by endogenous or pathogen-derived compounds, hypoxia by impaired microvascular regulation and septic shock as well as imbalance of neurotransmitters...
November 25, 2016: Expert Review of Anti-infective Therapy
https://www.readbyqxmd.com/read/27885865/delivering-phage-therapy-per-os-benefits-and-barriers
#7
Susan Zelasko, Andrzej Gorski, Krystyna Dabrowska
Multidrug-resistant bacterial infections of the gastrointestinal tract pose a serious public health concern. High levels of antibiotic drug resistance, along with the potential for antibiotics to precipitate disease or alter the gut microbiome has prompted research into alternative treatment methods. Evidence suggests that bacteriophage therapy delivered per os may be well-suited to target such infections. Areas covered: Herein, we discuss the specific advantages and challenges of using orally administered phage therapy...
November 25, 2016: Expert Review of Anti-infective Therapy
https://www.readbyqxmd.com/read/27858472/approaches-to-biofilm-associated-infections-the-need-for-standardized-and-relevant-biofilm-methods-for-clinical-applications
#8
Matthew Malone, Darla M Goeres, Iain Gosbell, Karen Vickery, Slade Jensen, Paul Stoodley
The concept of biofilms in human health and disease is now widely accepted as cause of chronic infection. Typically, biofilms show remarkable tolerance to many forms of treatments and the host immune response. This has led to vast increase in research to identify new (and sometimes old) anti-biofilm strategies that demonstrate effectiveness against these tolerant phenotypes. Areas covered: Unfortunately, a standardized methodological approach of biofilm models has not been adopted leading to a large disparity between testing conditions...
November 18, 2016: Expert Review of Anti-infective Therapy
https://www.readbyqxmd.com/read/27828734/anti-inflammatory-effects-of-the-new-generation-synthetic-surfactant-chf5633-on-ureaplasma-induced-cytokine-responses-in-human-monocytes
#9
K Glaser, M Fehrholz, B Henrich, H Claus, M Papsdorf, C P Speer
BACKGROUND: Synthetic surfactants represent a promising alternative to animal-derived preparations in the treatment of neonatal respiratory distress syndrome. The synthetic surfactant CHF5633 has proven biophysical effectiveness and, moreover, demonstrated anti-inflammatory effects in LPS-stimulated monocytes. With ureaplasmas being relevant pathogens in preterm lung inflammation, the present study addressed immunomodulatory features on Ureaplasma-induced monocyte cytokine responses. METHODS: Ureaplasma parvum-stimulated monocytes were exposed to CHF5633...
November 9, 2016: Expert Review of Anti-infective Therapy
https://www.readbyqxmd.com/read/27774825/optimum-treatment-of-vasopressor-dependent-distributive-shock
#10
Jean-Louis Vincent, Marc Leone
Distributive shock is associated with decreased systemic vascular resistance and altered oxygen extraction. Septic shock is the most frequent form of distributive shock. In shock states, duration of hypotension is associated with poor outcomes. The speed at which treatment to restore adequate perfusion pressure is initiated is, therefore, important to improve survival. Areas covered: This review presents an overview of the literature related to the management of vasopressor-dependent distributive shock, and in particular the relationship between arterial pressure and organ perfusion and function...
November 7, 2016: Expert Review of Anti-infective Therapy
https://www.readbyqxmd.com/read/27766913/patient-specific-risk-stratification-for-antimicrobial-resistance-and-possible-treatment-strategies-in-gram-negative-bacterial-infections
#11
Matteo Bassetti, Alessia Carnelutti, Maddalena Peghin
The isolation of multi-drug-resistant gram-negative (MDRGN) pathogens has progressively increased worldwide and has been associated with important delays in the prescription of an adequate antibiotic treatment, resulting in increased mortality rates. Patient's stratification for MDRGN infections to optimize the prescription of an adequate empiric antimicrobial regimen is crucial. Areas covered: This article covers MDRGN epidemiology, with a specific focus on risk factors for harbouring infections sustained by extended-spectrum-Beta-lactamase (ESBL), carbapenem resistant Enterobacteriacae (CRE), MDR Pseudomonas aeruginosa and MDR Acinetobacter baumanii...
November 7, 2016: Expert Review of Anti-infective Therapy
https://www.readbyqxmd.com/read/27797606/rilpivirine-emtricitabine-and-tenofovir-alafenamide-single-tablet-combination-for-the-treatment-of-hiv-1-infection-in-selected-patients
#12
Onyema Ogbuagu
Co-formulated rilpivirine, emtricitabine and tenofovir alafenamide (RPV/F/TAF) is the 6(th) single-tablet combination antiretroviral medication approved within the past decade for the treatment of HIV-1 infection. It was approved based on positive bioequivalence studies with already approved drugs with its component compounds, RPV and the single tablet regimen- elvitegravir, cobicistat, F/TAF. Areas covered: This article reviews the chemical, pharmacodynamic and pharmacokinetic properties, key drug interactions, and the efficacy, safety, tolerability and optimal clinical uses of the medication and/or its components in different patient populations...
October 31, 2016: Expert Review of Anti-infective Therapy
https://www.readbyqxmd.com/read/27796143/the-mechanistic-role-of-antibodies-to-dengue-virus-in-protection-and-disease-pathogenesis
#13
Esther Shuyi Gan, Donald Heng Rong Ting, Kuan Rong Chan
Dengue is a prevalent disease in tropical and subtropical countries with an estimated 400 million people infected annually. While significant advancement has been made in the chase for an effective dengue vaccine, the recently licensed Sanofi vaccine was, in contrast to in vitro data, only partially protective. Areas covered: This suggests that our understanding of the serological correlates for dengue is currently inadequate. With growing evidence supporting the role of fragment crystalizable gamma receptors (FcγRs) in antibody-mediated neutralization or antibody-dependent enhancement (ADE) of dengue virus (DENV) infection, FcγR-expressing cells have been increasingly used for measuring neutralizing antibody responses elicited by dengue vaccines...
October 31, 2016: Expert Review of Anti-infective Therapy
https://www.readbyqxmd.com/read/27791427/in-a-financially-driven-quest-for-antibiotic-stewardship-does-intensive-care-hold-the-key
#14
Stuart A Gillon, Duncan LA Wyncoll
No abstract text is available yet for this article.
October 28, 2016: Expert Review of Anti-infective Therapy
https://www.readbyqxmd.com/read/27790937/treatment-of-pulmonary-brucellosis-a-systematic-review
#15
Javier Solera, Julián Solís García Del Pozo
Pulmonary involvement is a rare, focal complication of human brucellosis. The aim of this review is to describe clinical and radiologic features, treatment administered and clinical course of these patients. Areas covered: We conducted a systematic search of scientific reports of brucellosis with pulmonary involvement published from January 1985 to July 2016. Four main patterns of disease were observed: pneumonia, pleural effusion, nodules and interstitial pattern. Cough and fever were the most common symptoms...
October 28, 2016: Expert Review of Anti-infective Therapy
https://www.readbyqxmd.com/read/27788612/a-european-survey-of-perendoscopic-treatment-of-biliary-complications-in-patients-with-alveolar-echinococcosis
#16
Sylvain Ambregna, Stéphane Koch, Michael C Sulz, Beate Grüner, Sümeyra Öztürk, Jean-Baptiste Chevaux, Małgorzata Sulima, Andrea de Gottardi, Bertrand Napoléon, Armand Abergel, Philippe Bichard, Isabelle Boytchev, Pierre Deprez, Jerome Dumortier, Jean-Louis Frossard, Eric Kull, Bernard Meny, Darius Moradpour, Fréderic Prat, Geoffroy Vanbiervliet, Thierry Thevenot, Dominique Angèle Vuitton, Solange Bresson-Hadni, Lucine Vuitton
BACKGROUND: Biliary complications represent a turning point in the course of Alveolar Echinococcosis (AE). We conducted a European survey to collect data on the current usage and results of perendoscopic interventions (PEIs) for their treatment. METHODS: Patient's characteristics and follow-up until January 31st, 2015 were recorded using an online questionnaire. RESULTS: From 18 centers 129 PEIs were analyzed in 38 patients; 139 plastic stents were inserted during 85 PEIs; median time between stent placements was significantly longer when 3 stents or more were placed...
October 28, 2016: Expert Review of Anti-infective Therapy
https://www.readbyqxmd.com/read/27786589/current-management-of-severe-dengue-infection
#17
Tau Hong Lee, Linda Kay Lee, David Chien Lye, Yee Sin Leo
Traditionally a disease mainly affecting the pediatric population, dengue burden has increased significantly in recent decades and adults with severe disease may become more common. There is currently no effective anti-viral agent available for the treatment of dengue and supportive care is the mainstay of management. Areas covered: We present a review of current literature on dengue severity classification systems and the management of severe dengue in adults. In particular, emphasis was placed on organ impairment in dengue and management of elderly individuals with multiple medical problems...
October 27, 2016: Expert Review of Anti-infective Therapy
https://www.readbyqxmd.com/read/27771978/challenges-and-opportunities-in-the-treatment-of-ventilator-associated-pneumonia
#18
Matthew P Schreiber, Andrew F Shorr
Ventilator-associated pneumonia (VAP) is a distinct clinical entity characterized by an onset after 48 hours of the application of mechanical ventilation (MV). Protocols exist to aid in the prevention of VAP, but this infection carries a devastating impact on patient morbidity and potentially mortality. Areas covered: In this review we present key concepts from existing guidelines to aid clinicians. Challenges remain in defining this disease and, most importantly appropriate empiric antimicrobial treatment is the main determinant of outcome...
October 24, 2016: Expert Review of Anti-infective Therapy
https://www.readbyqxmd.com/read/27762157/individualizing-management-of-extensively-drug-resistant-tuberculosis-diagnostics-treatment-and-biomarkers
#19
Jan-Willem Alffenaar, Onno W Akkerman, Richard Anthony, Simon Tiberi, Scott Heysell, M P Grobusch, Frank Cobelens, Dick van Soolingen
Success rates for treatment of extensively drug resistant tuberculosis (XDR-TB) are low due to limited treatment options, delayed diagnosis and inadequate health care infrastructure. Areas covered: This review analyses existing programmes of prevention, diagnosis and treatment of XDR-TB. Improved diagnostic procedures and rapid molecular tests help to select appropriate drugs and dosages. Drugs dosages can be further tailored to the specific conditions of the patient based on quantitative susceptibility testing of the M...
October 20, 2016: Expert Review of Anti-infective Therapy
https://www.readbyqxmd.com/read/27762148/strategies-to-limit-immune-activation-in-hiv-patients
#20
Alessandra Bandera, Elisa Colella, Giuliano Rizzardini, Andrea Gori, Mario Clerici
Antiretroviral treatment of HIV infection reduces, but does not eliminate, viral replication and down modulates immune activation. The persistence of low level HIV replication in the host, nevertheless, drives a smouldering degree of immune activation that is observed throughout the natural history of disease and is the main driving force sustaining morbidity and mortality. Areas covered: Early start of antiretroviral therapy (ART) and intensive management of behavioural risk factors are possible but, at best, marginally successful ways to manage immune activation...
October 20, 2016: Expert Review of Anti-infective Therapy
journal
journal
40471
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"